Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2415
+0.0042 (1.77%)
At close: Aug 13, 2025, 4:00 PM
0.2417
+0.0002 (0.08%)
Pre-market: Aug 14, 2025, 9:02 AM EDT
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$2,369,248
Market Cap
55.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RENB News
- 5 days ago - Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks - Accesswire
- 16 days ago - Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - Accesswire
- 4 weeks ago - Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy - Accesswire
- 5 weeks ago - Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives - Accesswire
- 6 weeks ago - Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs - Accesswire
- 2 months ago - Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform - GlobeNewsWire
- 2 months ago - UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - GlobeNewsWire
- 2 months ago - Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - GlobeNewsWire